Future Medicine India Magazine - January - March 2022Add to Favorites

Future Medicine India Magazine - January - March 2022Add to Favorites

Go Unlimited with Magzter GOLD

Read Future Medicine India along with 8,500+ other magazines & newspapers with just one subscription  View catalog

1 Month $9.99

1 Year$99.99 $49.99

$4/month

Save 50% Hurry, Offer Ends in 7 Days
(OR)

Subscribe only to Future Medicine India

Buy this issue $3.99

Subscription plans are currently unavailable for this magazine. If you are a Magzter GOLD user, you can read all the back issues with your subscription. If you are not a Magzter GOLD user, you can purchase the back issues and read them.

Gift Future Medicine India

In this issue

MAULING MYOCARDITIS : Mounting CVD risk is the latest to get added to India's pandemic-linked woes

DR JOSEPH J SARRET of CohBar on world's first natural peptides focussed novel drug discovery against NASH, IPF in in Straigh Talk

MICROSCOPE : An exclusive window to the world of latest medical research from this edition onwards

Early Reports On Omicron Encouraging: Anthony Fauci

Even as the Omicron variant of coronavirus is spreading across the world quickly, early reports suggest that it may cause less severe disease than the Delta variant, says Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, US.

Early Reports On Omicron Encouraging: Anthony Fauci

8 mins

Air Pollution Reduces 8 Years Of Life Expectancy In India

India registers 18 percent of deaths annually due to air pollution and related diseases, while nationwide socioeconomic inequalities persist in asthma diagnosis across India

Air Pollution Reduces 8 Years Of Life Expectancy In India

10+ mins

Importance Of Adhering To Covid Appropriate Behaviour

As the efficacy of existing vaccines has been proven to be inadequate against Omicron, our only hope from the jab is to reduce the severity of the disease, highlighting the importance of adhering to covid appropriate behaviour

10+ mins

AstraZeneca's new covid drug AZD7442 shows 83% prevention and 88% treatment efficacy

AstraZeneca, which announced the latest data from Phase III trials of its new Covid-19 drug -- AZD7442 -- said both the prevention and outpatient treatment studies showed robust efficacy from a onetime intramuscular (IM) dose of the long-acting antibody combination.

AstraZeneca's new covid drug AZD7442 shows 83% prevention and 88% treatment efficacy

1 min

VACCINES IN YOUR POCKET

DR. SAUMYA SWAMINATHAN Cheif Scientist, World Health Organisation

VACCINES IN YOUR POCKET

1 min

DIABETES, AT CLOSE TO 91 MILLION CASES, ACCOUNTS FOR 25% OF ALL NCDS IN INDIA

The disease incidence, which increases very rapidly in individuals above 35 years of age, accounts for 12.8 million DALYs, 6.7 million YLDs

DIABETES, AT CLOSE TO 91 MILLION CASES, ACCOUNTS FOR 25% OF ALL NCDS IN INDIA

4 mins

EXPERTS PREDICT THIRD WAVE IN INDIA WITH MORE THAN A LAKH DAILY CASES IN FEBRUARY

The active cases have come down as compared July leveld, the threat of new variants is looming large.

EXPERTS PREDICT THIRD WAVE IN INDIA WITH MORE THAN A LAKH DAILY CASES IN FEBRUARY

1 min

END INEQUALITIES TO MEET THE TARGET OF ENDING AIDS

Forty years after the first AIDS case was reported, and 35 years since the first case in India, HIV still threatens us. Today, the world is off track from delivering on the shared commitment to end AIDS by 2030.

END INEQUALITIES TO MEET THE TARGET OF ENDING AIDS

4 mins

CONVENTIONAL LINEN IS ONE OF THE BIGGEST CULPRITS IN HOSPITAL ACQUIRED AS WELL AS SURGICAL SITE INFECTIONS

The ‘green colour’ linen is synonymous with hospitals, as it has been in use for centuries in hospitals world over, especially the conventional healthcare settings. But how many, even in the medical community, are really conscious about the responsibility for and the critical role of this piece of medical accessory in ensuring patient safety? Evidence from most hospitals in India indicates that not many are aware of the standards, and even if they are, not many bother with them. Again, going by real world experience, there exists another paradox. Though the actual cost of the repeated use of the linen is higher than the cost of single-use disposables (recommended in modernday care), it is still being used in a large majority of hospitals and clinics in India — because it is the convention. Therefore, transformation hesitance is more of a mindset issue rather than ignorance or economics. Most in the industry also oppose quality regulations in the country. In a market where hundreds of textile weavers and cloth merchants turned medical mask and accessory manufacturers overnight during the Covid pandemic, the market situation serves the unscrupulous minds who only eye the profits. However, there are a handful of local companies, besides the large organised players, who stick to quality products in this predominently price conscious market due to internal SOPs or pure commitment. For JAMES GEORGE, Founder and Managing Director at Kochi-based Careon Healthcare Solutions, it is more of a personal commitment. In a freewheeling interview with Editor CH UNNIKRISHNAN, George says that the primary reason behind the rise of unscrupulous players in the medical disposables market is lack of awareness among the users and the patients. Edited excerpts:

CONVENTIONAL LINEN IS ONE OF THE BIGGEST CULPRITS IN HOSPITAL ACQUIRED AS WELL AS SURGICAL SITE INFECTIONS

5 mins

UK approves sotrovimab as new covid treatment for high risk adults

The Medicines and Healthcare Products Regulatory Agency (MHRA), the drug regulator of the UK, has approved sotrovimab, branded as Xevudy, a new biological drug to fight Covid-19. The drug was found effective to reduce the likelihood of hospital admission and death by about 79 percent in high-risk adults.

UK approves sotrovimab as new covid treatment for high risk adults

3 mins

Is TB Losing Attention?

In sub-Saharan Africa and Elsewhere, We Need to Look Harder for TB

Is TB Losing Attention?

3 mins

Critical Use Of Tractography In Removal Of Brain Tumours

Among Indian surgeons, it is rare to find the skilful art of using Diffusion Tensor Imaging-Fiber Tractography (DTI-FT), a novel MRI technique, to locate the facial nerve on the surface of the brain tumour before surgery

Critical Use Of Tractography In Removal Of Brain Tumours

4 mins

DIGITAL THERAPEUTICS: CHANGING PARADIGMS IN DIABETES CARE

With the emergence of DTx programs, doctors and healthcare staffcan extend their care and monitor a patient remotely for faster recovery

DIGITAL THERAPEUTICS: CHANGING PARADIGMS IN DIABETES CARE

3 mins

Remogliflozin, vildagliptin, metformin FDC approved for Type 2 Diabetes in India

Mumbai-based drumaker Glenmark Pharmaceuticals received approval for its fixed dose combination (FDC) of remogliflozin (100 mg), vildagliptin (50 mg) and metformin (500/ 1000 mg from the Drug Controller General of India.

Remogliflozin, vildagliptin, metformin FDC approved for Type 2 Diabetes in India

3 mins

FDA clears Pfizer-BioNTech vaccine for children

US drug regulator Food and Drug Administration has authorized the Pfizer-BioNTech COVID-19 Vaccine for children between 5 to 11 years of age.

FDA clears Pfizer-BioNTech vaccine for children

1 min

YOUNG MINDS THE MOST AFFECTED

11,396 CHILDREN DIED BY SUICIDE IN 2020, AN 18 PERCENT INCREASE FROM 2019 AND 21 PERCENT JUMP FROM 2018

4 mins

FALCON STUDY SUGGESTS CHANGE IN WHO GUIDELINES ON SSI PREVENTION

Use of alcoholic chlorhexidine skin preparation and triclosan coated sutures to prevent Surgical Site Infection showed no additional benefits

FALCON STUDY SUGGESTS CHANGE IN WHO GUIDELINES ON SSI PREVENTION

2 mins

THE COMPLEMENT - BEHIND ENEMY LINES

Despite a plethora of scientific literature available on SARSCoV2, SARS-CoV and MERS-CoV, there are still uncertainties that impede identification of new therapies

THE COMPLEMENT - BEHIND ENEMY LINES

4 mins

ROLE OF NUTRACEUTICALS IN MODERN HEALTHCARE

With the pandemic teaching us the importance of overall nutrition, people are getting more flexible toward nutraceuticals

ROLE OF NUTRACEUTICALS IN MODERN HEALTHCARE

5 mins

“WE WANT TO BE A LEADER IN GENETIC DIAGNOSTICS AS A DIFFERENTIATOR AND NOT AS A ME-TOO PLAYER”

TONY JOSE, Co-Founder and CEO of Bangalore- based genomics company Clevergene that claims unrivalled discovery-genomics and genetic diagnostics capabilities, had a personal reason to take a deep interest in genetics.

“WE WANT TO BE A LEADER IN GENETIC DIAGNOSTICS AS A DIFFERENTIATOR AND NOT AS A ME-TOO PLAYER”

7 mins

How Long Before Covid-19 Can At Least Be Curbed To The Endemic Stage?

Even as the prospect of COVID-19 turning endemic seems the likely long-term scenario for many countries, experts feel that even that will remain a distant dream for India

How Long Before Covid-19 Can At Least Be Curbed To The Endemic Stage?

10+ mins

Beating The Pandemic: The Best And The Worst

Globally, countries followed effective measures and appropriate social behaviour along with the vaccine intervention have almost won the fight while many are their level best to adhere to the protocols are on the way to win. However several top nations, irrespective of their developed and developing economy and healthcare status, are still in the woods as the pandemic cautions seemed compromised at many levels. (Country, total cases and current daily average)

Beating The Pandemic: The Best And The Worst

8 mins

Learnings From The 2nd Wave Of Covid

PSA plants could be the answer to battle Supply and Purity challenges in Medical Oxygen

Learnings From The 2nd Wave Of Covid

3 mins

Liposomal Nanotechnology and its role in vaccine delivery systems

In the recent past, there have been many projects to develop sub-unit vaccines that are more effective and defined

Liposomal Nanotechnology and its role in vaccine delivery systems

3 mins

CIDRAP RELEASES INFLUENZA VACCINES R&D ROADMAP TO IMPROVE FLU VACCINES

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, has released an Influenza Vaccines Research and Development Roadmap (IVR) to accelerate the development of improved seasonal influenza vaccines and the generation of broadly protective or universal influenza vaccines that could mitigate the impact of future influenza pandemics.

CIDRAP RELEASES INFLUENZA VACCINES R&D ROADMAP TO IMPROVE FLU VACCINES

6 mins

COVID-19 SEROLOGIC TESTING

IDSA GUIDELINES

COVID-19 SEROLOGIC TESTING

10+ mins

COVID-19 UPDATES

CDC PANEL BACKS PFIZER VACCINE BOOSTER SHOT FOR ADULTS

COVID-19 UPDATES

9 mins

Researchers find drug-resistant Malaria in Uganda

Researchers in Uganda analysed malaria patients and found a form of drug-resistant malaria disease, strengthening worries about the utilization of current drugs against the parasitic disease.

Researchers find drug-resistant Malaria in Uganda

8 mins

“CONNECTING THE PATIENT ON VIDEO WITH A DOCTOR IS NOT DIGITAL HEALTH, THERE IS MUCH MORE TO IT”

Digital health is the way forward for the world at a time when it is going through one of its most uncertain phases during which mobility has been affected, the economy is in peril and human health is in danger. In June, New York Stock Exchange saw the listing of a company that can truly impact the future of world healthcare in this context. UpHealth Holdings, Inc., which was born through a reverse merger of four companies, combines the four essential components of digital healthcare — a low cost, but accountable system of care, an integrated care management platform, a tech-enabled behavioral health service unit and a full-service e-pharmacy capability. The new entity, which began trading on the NYSE at $9.29 a share on June 10th, was formed by the merger of Glocal Healthcare, a social venture and one of India’s pioneer digital health companies, and three US-based entities Thrasys, BHS & Transformations, and MedQuest. The company focuses on the three As of future healthcare — access anywhere, affordability for everyone and accountability of health outcomes. The founder of Glocal Healthcare and the chief architect of this new global healthcare fusion, DR SYED SABAHAT AZIM — a physician and former Indian Administrative Service (IAS) official, envisioned this a long time ago when he founded Glocal in 2010. Glocal was conceived as a social enterprise bringing quality healthcare to rural India through a combination of low cost primary and secondary care hospitals and digital dispensaries powered by technology. However, says he, the majority of the world, including people engaged in the service of healthcare, is yet to fully understand ‘digital health’ and ‘telemedicine’. Dr Sabahat says the term digital health is often misinterpreted even by healthcare providers, in an exclusive interview with Editor CH UNNIKRISHNAN.

“CONNECTING THE PATIENT ON VIDEO WITH A DOCTOR IS NOT DIGITAL HEALTH, THERE IS MUCH MORE TO IT”

8 mins

SARS-COV-2 Re-Infection And Vaccine Development

The molecular mechanisms behind the human immune response to SARS-CoV-2 need to be examined thoroughly to design effective vaccines

4 mins

Read all stories from Future Medicine India

Future Medicine India Magazine Description:

PublisherNextGen Science Media Pvt Ltd

CategoryHealth

LanguageEnglish

FrequencyMonthly

Future Medicine is a monthly medical science and news magazine, specially designed and developed for the medical fraternity of India. It empowers clinicians with the knowledge of latest breakthroughs in science, provides prompt updates on emerging medical and industry trends. It imparts timely news, views and analysis of tomorrow’s science, along with a discussion forum of medical science experts, who can predict and influence the future of healthcare.

Future Medicine’s multi-format approach allows new-age medical and life sciences professionals to browse through topics that most appeal to them, put forth in an easy-to-understand and interesting manner. The primary focus is on bridging the gap between medical researchers and clinicians. Future Medicine ushers a refreshing change in the manner of scientific information access within the field of medical science.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
MAGZTER IN THE PRESS:View All